The total return over the past 12 months is +16.82% vs. +17.77% for the S&P 500. So far it's up -14.78% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +16.19% | (3.37%) | +2.27% | +5.30% | +17.62% | +22.10% |
| Total Return CAGR | +16.82% | (3.11%) | +2.43% | +5.38% | +17.68% | +22.15% |
| Revenue CAGR | +5.92% | +6.44% | +10.16% | +12.90% | +25.96% | +30.92% |
| Net Income CAGR | (1.69%) | +1.88% | +2.01% | +19.81% | +24.55% | +24.55% |
| EPS CAGR | +5.31% | +2.06% | +5.70% | +21.44% | +21.27% | +21.27% |
| Free Cash Flow CAGR | +37.58% | +4.37% | +15.42% | +17.77% | +64.27% | +26.83% |
| Operating Cash Flow CAGR | +26.80% | +5.40% | +14.13% | +13.00% | +30.19% | +26.70% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Regeneron Pharmaceuticals, Inc. (REGN)
| Year | Start Value | End Value | REGN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 5215.49 | 4444.39 | (14.78%) | +8.94% | (23.72%) |
| 2025 | 4787.16 | 5215.49 | +8.95% | +17.72% | (8.77%) |
| 2024 | 5902.49 | 4787.16 | (18.90%) | +24.89% | (43.79%) |
| 2023 | 4848.72 | 5902.49 | +21.73% | +26.19% | (4.46%) |
| 2022 | 4244.09 | 4848.72 | +14.25% | (18.17%) | +32.42% |
| 2021 | 3246.71 | 4244.09 | +30.72% | +28.74% | +1.98% |
| 2020 | 2523.39 | 3246.71 | +28.66% | +18.37% | +10.29% |
| 2019 | 2510.08 | 2523.39 | +0.53% | +31.22% | (30.69%) |
| 2018 | 2526.61 | 2510.08 | (0.65%) | (4.56%) | +3.91% |
| 2017 | 2467.00 | 2526.61 | +2.42% | +21.70% | (19.28%) |
